Treatment of Livedoid Vasculopathy With Rivaroxaban: A Potential Use of New Oral Anticoagulants for Dermatologists

Jiménez-Gallo, D.; Villegas-Romero, I.; Rodríguez-Mateos, M.E.; Linares-Barrios, M.

doi:10.1016/j.adengl.2018.02.009

Case and Research Letters

Treatment of Livedoid Vasculopathy With Rivaroxaban: A Potential Use of New Oral Anticoagulants for Dermatologists

Vasculopatía livedoide tratada con rivaroxabán. Potenciales usos de los nuevos anticoagulantes orales para el dermatólogo

D. Jiménez-Galloa,

,

, I. Villegas-Romeroa, M.E. Rodríguez-Mateosb, M. Linares-Barriosa

a Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Puerta del Mar, Cádiz, España

b Unidad de Gestión Clínica de Farmacia Hospitalaria, Hospital Universitario Puerta del Mar, Cádiz, España

Article

To access the full text of the publication Actas Dermo-Sifiliográficas you need to be a subscriber or member of the Academia Española de Dermatología y Venereología.

If you are a member of the Academia Española de Dermatología y Venereología::
- If this is your first time in the Web:
  You can get your login by contacting Elsevier Spain in: or through the customer service phone 902 88 87 40 http://www.aedv.es/loginor through the customer service phone 902 88 87 40.
  
  Calling from Spain
  902 88 87 40 (from 9 to 18 h)
  Calling from outside Spain
  +34 932 418 800 (from 9 to 18 h)
If you are a subscriber:
Can you recover your data in the "I Forgot my Password" button on the right sidebar of this website.